Determining the protective effect of a boron adjuvanted vaccine with an experimental infection model in mice

dc.authorid0000-0001-6096-4440
dc.authorid0000-0002-8319-831X
dc.authorid0000-0002-5745-3073
dc.authorid0000-0002-7266-1049
dc.authorid0000-0002-2677-179X
dc.authorid0000-0003-4564-2077
dc.authorid0000-0002-9340-9360
dc.contributor.authorSayın, Zafer
dc.contributor.authorUslu, Ali
dc.contributor.authorÖzdemir, Özgür
dc.contributor.authorBaşoğlu, Abdullah
dc.contributor.authorBalevi, Aslı
dc.contributor.authorUçan, Uçkun Sait
dc.contributor.authorAras, Zeki
dc.contributor.authorErganiş, Osman
dc.date.accessioned2024-03-20T11:23:30Z
dc.date.available2024-03-20T11:23:30Z
dc.date.issued2023
dc.departmentVeteriner Fakültesi
dc.description.abstractBoron is a required trace element for plants, humans, and animals and it has significant influence over biological functions and the immune system. Vaccines have aided humans in the control of many contagious diseases around the world. The success of global immunization campaigns may be possible with the development of effective and low-cost vaccines and adjuvants. For this reason, the present study aimed to determine the adjuvant activity of easily accessible boron compounds. In this study, six different vaccines were prepared, including inactive Staphylococcus aureus bacteria, boric acid, aluminum hydroxide, montanide ISA 50, and ISA 206, ISA 50 + boric acid, and ISA 206 + boric acid combinations. The rate of survival following the challenge, the bacterial load on internal organs, and histopathological findings at the vaccine injection site and in the internal organs were evaluated in vaccinated mice. In addition, the levels of interferon - ? and tumor necrosis factor - ? were measured in the vaccinated seropotency groups. The rate of postchallenge mortality was 50% in the control group, and no mortality was encountered in the boric acid group. The boric acid adjuvanted vaccine decreased the bacterial load and postchallenge abscess in the internal organs and also local inflammatory reactions due to montanide adjuvants in combinations. No difference was found in the interferon - ? and tumor necrosis factor - ? levels between the control and vaccine groups. It was concluded that boric acid can be used as an adjuvant in inactivated vaccines.
dc.identifier.doi10.55730/1300-0128.4313
dc.identifier.endpage456en_US
dc.identifier.issue5en_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage446en_US
dc.identifier.uri10.55730/1300-0128.4313
dc.identifier.urihttps://hdl.handle.net/20.500.12451/11490
dc.identifier.volume47en_US
dc.identifier.wosWOS:001094387200003
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherTÜBİTAK
dc.relation.ispartofTurkish Journal of Veterinary and Animal Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdjuvant Aluminum
dc.subjectBoron
dc.subjectChallenge
dc.subjectVaccine
dc.titleDetermining the protective effect of a boron adjuvanted vaccine with an experimental infection model in mice
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
sayin-zafer-2023.pdf
Boyut:
2.18 MB
Biçim:
Adobe Portable Document Format
Açıklama:
https:/dx.doi.org
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: